Advertisement
Home »

RELIEVE-HF: Interatrial Shunt May Prove Advantageous for Patients With HFrEF

Apr 19, 2024

REFERENCES & ADDITIONAL READING

Stone G. A double-blind, randomized placebo procedure-controlled trial of an interatrial shunt in patients with HfrEF and HfpEF: principal results from the RELIEVE-HF trial. LB1, Session 402. Presented at: ACC 2024 Scientific Session, April 6-8, 2024, Atlanta, GA.

 

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement